Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 2 of 2 entries
View as:
Phase: N/A
Priority: Normal
Start: 11/30/05
End: 12/31/07
Due: 12/31/08
Phase: N/A
Priority: Normal
Start: 10/31/06
End: 09/30/08
Due: 09/30/09
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| PROVIDENCE-1: Study of Rifalazil in Chlamydia Pneumoniae Seropositive Patients | NCT00251849 | ActivBiotics | user2@example.com | None | 2005-11-30 | 2007-12-31 | 2008-12-31 | - | - | 2025-07-14 |
| RESTORE-IT-Study of Rifalazil in Chlamydia Pneumoniae Seropositive Patients With a History of Atherosclerotic Disease | NCT00385385 | ActivBiotics | user2@example.com | None | 2006-10-31 | 2008-09-30 | 2009-09-30 | - | - | 2025-07-14 |